Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Holdings
Biotech
Novo Holdings assets shrink by 3rd as Novo Nordisk shares fall
Novo Holdings saw its assets shrink by a third last year as part of the fallout of Novo Nordisk’s nosediving share price.
James Waldron
Mar 12, 2026 7:15am
European VCs join forces to boost regional biotech investment
Feb 12, 2026 5:00am
JPM26: All of the meetings, none of the megadeals
Jan 15, 2026 4:30am
Global uncertainties can't dampen upbeat Jefferies conference
Nov 24, 2025 3:00am
Expedition resupplies for ph. 2 COPD voyage with $165M series A
Oct 9, 2025 9:50am
Novo Holdings-backed biotech raises $205M to fill gout care gap
Sep 30, 2025 8:00am